Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 59 Schemes (27.19%)
Foreign Institutions
Held by 95 Foreign Institutions (16.42%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
181 Million
(Quarterly Results - Sep 2025)
Net Profit:
18 Million
Pharmaceuticals & Biotechnology
USD 3,621 Million (Small Cap)
603.00
NA
0.00%
-0.65
-999,999.00%
6.76






